Quintiles Wins Pfizer Development Operations Strategic Supplier Excellence Award


Company News Release

RESEARCH TRIANGLE PARK, NC-Quintiles Transnational Corp. today announced that its Data Management division has received the 2008 Pfizer Development Operations’ Strategic Supplier Excellence Award.

Pfizer presents the award to their Development Operations Functional Service Providers (FSPs) that demonstrate consistent and excellent performance in four areas: quality; service delivery and reliability; innovation and business processes; and customer service and responsiveness.

“Quintiles has consistently demonstrated superior performance and partnership by working to reduce timelines and streamline processes, adding high value to the Data Management business,” said Rob Goodwin, Vice President of Global Clinical Data Services, Pfizer.

Quintiles executives said the value of the partnership is enhanced by the strength of the Pfizer-Quintiles relationship.

“The Pfizer and Quintiles teams have worked closely together to lock databases ahead of schedule, increase productivity and achieve cost savings,” said Theo Erasmus, Vice President, Global Data Management, Quintiles Africa, who heads the FSP with Pfizer. “A major reason for our successful relationship is proactive communication. By maintaining an open dialogue, we’ve been able to increase quality, improve processes and encourage innovation.”

“We are honored and delighted to be selected for this award because it recognizes what can be achieved through open, honest collaboration and teamwork,” said Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, Quintiles. “We look forward to building an even stronger relationship with our colleagues at Pfizer and building on our successes for 2009.”

Quintiles supports Pfizer data management primarily from locations in Bloemfontein, South Africa and Bangalore, India.

About Quintiles
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of 23,000 engaged professionals in more than 50 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.